Clinician's Roundtable
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
91-105 of 3462
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's RoundtableAdherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
Improving CRC Screening Uptake: An Integrated Approach
Clinician's RoundtableImproving CRC Screening Uptake: An Integrated Approach
Mallik Greene, PhD
The Stepping Stones to Better Colorectal Cancer Screening
Clinician's RoundtableThe Stepping Stones to Better Colorectal Cancer Screening
Harish Gagneja, MD
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's RoundtableRisk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's RoundtableThe Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Christopher Cann, MD
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Peter Buch, MD, FACG, AGAF, FACP
Michael Dougherty, MD
- advertisement
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's RoundtableUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Ashley Baker, MSN, PMHNP
Heather Allen, PhD
Ran Li, PhD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's RoundtableBlood-Based Screening for Colorectal Cancer: Benefits and Limitations
Aasma Shaukat, MD, MPH
Geoffrey Chupp, MD
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Project Oncology®Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
John Russell, MD
Richard Wender, MD
- advertisement
Repeat mt-sDNA Screening for Colorectal Cancer in Underserved Populations
Clinician's RoundtableRepeat mt-sDNA Screening for Colorectal Cancer in Underserved Populations
Using Biomarkers to Guide Severe Asthma Treatment
Clinician's RoundtableUsing Biomarkers to Guide Severe Asthma Treatment
Geoffrey Chupp, MD
The Silent Clues Behind IgA Nephropathy Diagnosis
Clinician's RoundtableThe Silent Clues Behind IgA Nephropathy Diagnosis
Abdallah Geara, MD
